Biotechnology News

March 20, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A recent study found that medical affairs team resources fluctuate alongside product lifecycles, with budgets largely being consumed by medical communications.

March 20, 2014

WASHINGTON--(BUSINESS WIRE)--Sir Richard Branson, founder of the Virgin Group, will be interviewed during the keynote lunch Tuesday, June 24th from 12:00 – 1:30 pm at the 2014 BIO International Convention® in San Diego.

March 20, 2014

GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte®, Inc., the pioneer in scalable, high-performance cell transfection systems, will present data in both a scientific talk and a poster during the World Vaccine Congress on March 24-26, 2014, that...

March 20, 2014

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will release its first quarter 2014 financial results on Thursday, May 1, 2014 at 7:00 a.m. ET. Teva will host a conference call and live webcast...

March 20, 2014

AVON, Conn.--(BUSINESS WIRE)--Magellan Rx Management, a division of Magellan Health Services, Inc., today announced the launch of MRxAudit, a comprehensive tool to help determine the effectiveness of PBM services.

March 20, 2014

CARLSBAD, Calif. & NEW YORK & TURIN, Italy--(BUSINESS WIRE)--Over 2,000 life science executives attended the eighth annual BIO-Europe Spring® international partnering conference last week, March 10–12, in Turin, Italy.

March 20, 2014

SEATTLE--(BUSINESS WIRE)--TapImmune Inc. (OTCQB: TPIVD), a clinical stage immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease has filed a new patent...

March 20, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Envisia Therapeutics today announced that it will present data for ENV515, the company’s lead glaucoma product candidate, as well as preliminary data for the company’s novel drug delivery systems...

March 20, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative...

March 20, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics to Present Data on Product Candidates at the ARVO 2014 Annual Meeting

March 20, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Pfizer’s vaccine candidate, bivalent rLP2086, currently under...

March 20, 2014

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic (OSE:DIAG): Lars Christian Stugaard (32) has been appointed as acting Chief Executive Officer (CEO) of DiaGenic ASA on an interim basis effective from 1st April 2014. Mr. Stugaard holds the...

March 20, 2014

SAN DIEGO & VANCOUVER, British Columbia--(BUSINESS WIRE)--Sophiris Bio Inc. (NASDAQ: SPHS), a biopharmaceutical company developing a clinical stage, targeted treatment for the symptoms of BPH appointed Gerald T. Proehl to its board of...

March 20, 2014

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--NDA for Eagle Pharmaceuticals’ Orphan Drug Ryanodex® for the Treatment of Malignant Hyperthermia Accepted by FDA, Priority Review Granted

March 20, 2014

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) will present at the 2nd Annual Regen Med Investor Day to be held Wednesday, March 26, 2014 in New York City. Organized by the Alliance for Regenerative Medicine (ARM) in partnership...

March 20, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics today announced the pricing of its initial public offering (IPO) of 5,882,353 shares of common stock at an initial public offering price of $17.00 per share.

March 20, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical announces the European launch of Prodigy™ Chronic Pain System with Burst Technology — the first and only implantable neuromodulation system that delivers Burst stimulation.

March 20, 2014

BOUDRY, Switzerland--(BUSINESS WIRE)--A unique and extensive survey provides the first-of-its-kind multinational look into the impact psoriasis and psoriatic arthritis (PsA) have on patients’ lives, revealing several areas which warrant further...

March 20, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. today announced the addition of Hans-Peter Hartung, MD, PhD, FRCP and Timothy Barabe to join the Company’s Board of Directors.

March 20, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma (Nasdaq:XLRN) to present at the 21st Annual Future Leaders in the Biotech Industry Conference to be held on March 28, 2014 in NYC.

March 20, 2014

BELGRADE, Mont.--(BUSINESS WIRE)--Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft materials and bioactive coatings for medical applications, announces that results utilizing...

March 20, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ:VSTM) focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that members of the management team will be participating in the...

March 20, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ:TRVN), a clinical stage pharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced financial results for the...

March 20, 2014

NEW YORK--(BUSINESS WIRE)--ContraVir Appoints James Sapirstein as Chief Executive Officer and Board Member

March 20, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Announces Positive Interim Results from the ENCHANT-1 Trial of Ganetespib in Metastatic Breast Cancer at the 9th European Breast Cancer Conference

March 20, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN) today announced that GlaxoSmithKline’s (NYSE: GSK) MAGRITi study, a Phase 3 randomized, blinded, placebo-controlled MAGE-A3ii cancer immunotherapeutic trial in non-small cell lung...

March 20, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) announced today that Mayroy, its controlling shareholder, had completed an institutional private placement of 5 888 290 shares representing c.7% of Ipsen's...

March 19, 2014

BOULDER, Colo.--(BUSINESS WIRE)--The Shuman Law Firm investigates Galena Biopharma, Inc. (Nasdaq: GALE).

March 19, 2014

NEW YORK--(BUSINESS WIRE)--INTERPHEX (International Pharmaceutical Expo) the leading annual trade event dedicated to the pharmaceutical and biopharmaceutical manufacturing industry is being held this week at the Jacob K. Javits Center in New York...

March 19, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals provided an update on the Oral Explanation meeting with the Committee for Medicinal Products for Human Use (CHMP) of the EMA for the pending MAA of Lymphoseek®.

March 19, 2014

WASHINGTON--(BUSINESS WIRE)--BIO announces Dr. Calestous Juma at the Harvard Kennedy School and Dr. Jim Murray at the University of California at Davis to deliver the keynote addresses at the 2014 BIO Livestock Biotech Summit.

March 19, 2014

BOSTON--(BUSINESS WIRE)--Thermo Fisher Scientific and researchers at Harvard Medical School have teamed up to develop promising new ways to perform protein quantitation on a much larger scale than currently possible.

March 19, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Covidien plc (NYSE: COV) announced the results from today’s Annual General Meeting. Seven proposals were on the meeting agenda: Election of Directors Appointment of Independent Auditors An advisory vote to...

March 19, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that George A. Scangos, Ph.D., chief executive officer and director of Biogen Idec Inc., has been appointed to Agilent’s board of directors and will join...

March 19, 2014

BELGRADE, Mont.--(BUSINESS WIRE)--Bacterin (NYSE MKT: BONE) Announces Full Year 2013 Results

March 19, 2014

SANFORD, Maine--(BUSINESS WIRE)--The Baker Company launched a new visual brand identity that will define a new era of technologies designed to help customers advance and achieve excellence in scientific work and clinical care.

March 19, 2014

TEMPE, Ariz.--(BUSINESS WIRE)--Susavion Biosciences was selected to present its novel immunotherapeutic drugs for Oncology and Infectious Diseases at the Cavendish Global Health Impact Forum in May at the U.N. Headquarters.

March 19, 2014

MINNEAPOLIS--(BUSINESS WIRE)--LifeScience Alley announces that Dale Wahlstrom will retire August 15, 2014, but will step down as President & CEO effective May 1. The Board has selected EVP & COO Shaye Mandle as his successor.

March 19, 2014

LILLE, France & BOSTON--(BUSINESS WIRE)--GENFIT DEMONSTRATES THAT GFT505 ELIMINATES NASH AND FIBROSIS IN A CLINICALLY RELEVANT DISEASE MODEL.

March 19, 2014

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (OMX Nordic Exchange: AERO)(STO:AERO-B) announces that Health Care Service Corporation will begin covering FeNO testing for asthma diagnosis and management effective April 1, 2014....

March 19, 2014

MORRISTOWN, N.J.--(BUSINESS WIRE)--QPharma, Inc., a leading compliance and commercial solutions firm serving the life sciences industry, has announced the appointment of Matt Crusan to the position of Director, DEA Compliance and Services. A...

March 19, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMC™) technology for clinical diagnostics and scientific discovery, yesterday presented new data at the American Heart Association...

March 19, 2014

CRANBURY, N.J.--(BUSINESS WIRE)--NJ biotech VaxInnate begins a Phase I clinical trial of a recombinant quadrivalent vaccine to prevent seasonal flu. The vaccine candidate is based on the firm's breakthrough technology platform.

March 19, 2014

SEATTLE--(BUSINESS WIRE)--TapImmune Inc. (OTCQB: TPIVD), A clinical stage immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease has signed an exclusive option...

March 19, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND management will ring the Opening Bell at the NASDAQ MarketSite in Times Square, New York at 9:30 a.m. ET on Wednesday, March 26, 2014

March 19, 2014

AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics (Mirna), a private, clinical stage biopharmaceutical company focused on the development of microRNA-based oncology therapeutics, today announced Casi DeYoung has joined the company as chief...

March 19, 2014

VANCOUVER, Wash.--(BUSINESS WIRE)--CytoDyn Inc. (OTCQB: CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced today that the Company will host a live...

March 19, 2014

NEWARK, Del.--(BUSINESS WIRE)--New technologies to produce vaccines more safely, quickly and economically than traditional approaches are featured at the New Vaccines 2014: How New Science is Shaping Regulatory and Business Decisions...